Adage Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-182,995
Closed -$4.02M 1075
2025
Q4
$4.02M Buy
+182,995
New +$3.3M 0.01% 783
2025
Q3
Sell
-250,000
Closed -$4.66M 978
2025
Q2
$4.66M Buy
+250,000
New +$4.95M 0.01% 712
2024
Q4
Sell
-159,604
Closed -$6.77M 957
2024
Q3
$6.77M Buy
159,604
+94,604
+146% +$4.01M 0.01% 681
2024
Q2
$2.62M Sell
65,000
-53,709
-45% -$2.24M ﹤0.01% 766
2024
Q1
$4.2M Buy
+118,709
New +$3.18M 0.01% 716
2023
Q2
Sell
-250,000
Closed -$10.2M 929
2023
Q1
$10.2M Buy
250,000
+50,000
+25% +$2.07M 0.02% 613
2022
Q4
$8.99M Buy
+200,000
New +$9.05M 0.02% 661
2018
Q3
Sell
-150,000
Closed -$3.3M 762
2018
Q2
$3.3M Buy
+150,000
New +$1.84M 0.01% 676
2017
Q4
Sell
-50,000
Closed -$365K 750
2017
Q3
$365K Hold
50,000
﹤0.01% 704
2017
Q2
$400K Sell
50,000
-46,405
-48% -$429K ﹤0.01% 696
2017
Q1
$1.16M Buy
+96,405
New +$2.11M ﹤0.01% 678

Other funds holding TNDM

Adage Capital Partners's TNDM Position: Q1 2026 in Review

Adage Capital Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 182,995 shares — an estimated $4.02M sold.

Adage Capital Partners first reported a position in TNDM in Q1 2017 and held it in 11 quarters. The position peaked at $10.2M in Q1 2023. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Adage Capital Partners reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Adage Capital Partners sold 182,995 Tandem Diabetes Care shares in Q1 2026, an estimated $4.02M.
  • Adage Capital Partners first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 11 quarters.
  • Adage Capital Partners's Tandem Diabetes Care position peaked at $10.2M in Q1 2023.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.